TXN(TXN)
TXN
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $21.02B | $23.38B | $25.71B | $28.71B | $30.74B |
| Low | $20.05B | $21.53B | $25.62B | $26.68B | $28.57B |
| High | $21.74B | $24.90B | $25.79B | $31.17B | $33.37B |
| EBITDA Avg | $10.81B | $12.03B | $13.22B | $14.77B | $15.81B |
| Low | $10.31B | $11.07B | $13.18B | $13.72B | $14.69B |
| High | $11.18B | $12.81B | $13.26B | $16.03B | $17.17B |
| EBIT Avg | $9.19B | $10.22B | $11.24B | $12.55B | $13.44B |
| Low | $8.77B | $9.41B | $11.20B | $11.67B | $12.49B |
| High | $9.50B | $10.89B | $11.28B | $13.63B | $14.59B |
| Net Income Avg | $7.03B | $8.12B | $9.25B | $10.63B | $11.10B |
| Low | $6.47B | $7.27B | $7.03B | $9.65B | $10.08B |
| High | $7.49B | $9.77B | $11.71B | $11.81B | $12.34B |
| EPS Avg | $7.70 | $8.95 | $10.08 | $11.64 | $12.16 |
| Low | $7.09 | $7.96 | $7.70 | $10.57 | $11.04 |
| High | $8.21 | $10.70 | $12.83 | $12.94 | $13.51 |
| Analysts (Rev / EPS) | 25 / 23 | 25 / 22 | 18 / 13 | 11 / 11 | 9 / 5 |
| Metric | Q2 2026 | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $5.23B | $5.56B | $5.38B | $5.42B | $5.76B | $6.13B | $5.93B | $6.13B |
| Low | $5.21B | $5.12B | $5.06B | $5.10B | $5.42B | $5.77B | $5.58B | $5.77B |
| High | $5.32B | $5.84B | $5.62B | $5.66B | $6.02B | $6.40B | $6.19B | $6.40B |
| EBITDA Avg | $2.69B | $2.86B | $2.77B | $2.79B | $2.96B | $3.15B | $3.05B | $3.15B |
| Low | $2.68B | $2.64B | $2.60B | $2.62B | $2.79B | $2.97B | $2.87B | $2.97B |
| High | $2.74B | $3.00B | $2.89B | $2.91B | $3.09B | $3.29B | $3.19B | $3.29B |
| EBIT Avg | $2.29B | $2.43B | $2.35B | $2.37B | $2.52B | $2.68B | $2.59B | $2.68B |
| Low | $2.28B | $2.24B | $2.21B | $2.23B | $2.37B | $2.52B | $2.44B | $2.52B |
| High | $2.33B | $2.55B | $2.46B | $2.47B | $2.63B | $2.80B | $2.71B | $2.80B |
| Net Income Avg | $1.75B | $1.95B | $1.83B | $1.83B | $2.02B | $2.23B | $2.10B | $2.21B |
| Low | $1.65B | $1.71B | $1.69B | $1.69B | $1.86B | $2.06B | $1.94B | $2.04B |
| High | $1.82B | $2.11B | $1.94B | $1.93B | $2.13B | $2.36B | $2.22B | $2.34B |
| EPS Avg | $1.92 | $2.13 | $2.01 | $2.00 | $2.20 | $2.44 | $2.30 | $2.42 |
| Low | $1.81 | $1.87 | $1.85 | $1.85 | $2.04 | $2.26 | $2.12 | $2.23 |
| High | $1.99 | $2.31 | $2.12 | $2.11 | $2.33 | $2.59 | $2.43 | $2.56 |
| Analysts (Rev / EPS) | 17 / 17 | 17 / 17 | 8 / 7 | 8 / 7 | 8 / 7 | 11 / 10 | 8 / 7 | 10 / 11 |